Table 3 The median number of biomarkers and treatment options, as identified by Heidelberg and Berlin MTBs, respectively. The median number of types of alterations is also provided for biomarkers. Each predictive biomarker was counted once, irrespective of the number of resulting treatment options
Interpretations | Heidelberg | Berlin |
|---|---|---|
Biomarker, no. | ||
Median (range) | 4 (2–14) | 4 (1–21) |
Single nucleotide variants | 1 (0–6) | 1 (0–4) |
Structural variants | 1 (0–5) | 1 (0–13) |
Gene fusions | 0 (0–1) | 0 (0–1) |
Gene expression outlier | 2 (0–7) | 1 (0–5) |
Signatures | 0 (0–3) | 0 (0–1) |
Treatment options, no. | ||
Median (range) | 3 (1–5) | 2 (1–6) |